XII SEPNWG Meeting and IPNA Teaching Course
The Clinic of Pediatric Nephrology and Hemodialysis at Specialized hospital for active treatment of childhood diseases “Prof. Ivan Mitev” is organizing a training course and the XIIth Meeting of the Southeastern Europe Pediatric Nephrology Working Group (SEPNWG), which will be held under the auspices of the International Pediatric Nephrology Association (IPNA) on October 16–17, 2026, at the conference center of the Hyatt Regency Sofia Hotel, Sofia.
The forum is supported by the Bulgarian Pediatric Association and the Bulgarian Society of Nephrology.
The theme of the meeting is: “Glomerulopathies – Past, Present, Future”
Glomerulopathies are among the most serious diseases in pediatric nephrology, accounting for approximately 25% of chronic kidney disease cases in childhood and often leading to the need for renal replacement therapy. Proper and timely diagnosis, along with modern therapeutic approaches, makes this topic extremely important for the education and practical training of young physicians and specialists.
The training course is suitable for residents and specialists in the following fields: Pediatric Nephrology and Hemodialysis, Pediatric Rheumatology, and Pediatrics.
The first SEPNWG meeting was held in 2001 in Istanbul, with the mission to provide children with kidney diseases in Southeastern Europe with timely and high-quality nephrological care. Today, more than two decades later, the annual meetings continue to serve as a platform for professional exchange, discussion of current issues, and the development of valuable scientific and clinical partnerships.
Be part of this significant event and join us in our mission to support children’s health.
SCIENTIFIC COMMITTEE
Chair
CONSTANTINOS STEFANIDIS (ATHENS, GREECE)
Main topics:
- NS and SRNS
- IgA nephropathy
- C3 glomerulonephritis, IC-MPGN, aHUS
- Membranous glomerulonephritis
- Acute post-infectious glomerulonephritis
- Secondary glomerulonephritides – lupus nephritis, ANCA-associated, etc.
- Clinico-pathological correlation
- Genetics in glomerulopathy
| Working language of the event – ENGLISH! |
SCIENTIFIC PROGRAM
19:00–20:00
Business Meeting
ORGANIZING COMMITTEE
07:30–08:30
Registration
08:30–08:40
Opening Remark
First session
SSNS and SRNS (Part 1)
Chairs:
DIETER HAFFNER
(Hannover, Germany)
VELIBOR TASIĆ
(Skopje, North Macedonia)
08:40–09:00
Oral 1
SSNS
FRANCESKO EMMA
(Rome, Italy)
09:00–09:20
Oral 2
Volume assessment in nephrotic syndrome
GRETA MIHNEVA
(Sofia, Bulgaria)
09:20–09:40
Oral 3
The role of Rituximab in nephrotic syndrome
KJELL TULLUS
(London, UK)
09:40–10:00
Oral 4
Histological challenges of childhood nephrotic syndrome: one "new old story"
JULIAN ANANIEV
(Stara Zagora, Bulgaria)
10:00–10:10
10:10–10:40
Coffee Break
Second session
SSNS and SRNS (Part 2)
Chairs:
KJELL TULLUS
(London, UK)
DANKA POKRAJAC
(Saraevo, BiH)
10:40–11:00
Oral 5
SRNS: Lessons from the IPNA guideline
DIETER HAFFNER
(Hannover, Germany)
11:00–11:20
Oral 6
The genetics of SRNS – what’s next?
OLGA BELTCHEVA
(Sofia, Bulgaria)
11:20–11:40
Oral 7
Role of immunosuppression or other treatment options in genetic podocytopathies
GEORGIA MALAKASIOTI
(Athens, Greece)
11:40–12:00
Oral 8
SRNS in Bulgarian children – one center experience
12:00–12:10
Discussion
12:10–13:30
Lunch Break
13:30–14:00
Scientific symposium
Primary hyperoxaluria Type 1 (PH1) in children
CONSTANTINOS STEFANIDIS
(Athens, Greece)
Third session
IgA nephropathy
Chairs:
FRANCESCO EMMA
(Rome, Italy)
PATRICIA COSTA-REIS
(Lisbon, Portugal)
14:00–14:20
Oral 9
IPNA clinical practice recommendations on IgA nephropathy
DIETER HAFFNER
(Hannover, Germany)
14:20–14:40
Oral 10
Recent advances in pediatric IgA nephropathy
DANKO MILOSEVIC
(Zagreb, Croatia)
14:40–15:00
Oral 11
Association of glutathione transferase gene polymorphisms with IgA vasculitis disease severity
DANIEL TURUDIC
(Zagreb, Croatia)
15:00–15:10
Discussion
15:10–15:40
Coffee Break
15:40–16:00
Scientific symposium
aHUS
DIMITAR ROUSSINOV
(Sofia, Bulgaria)
Fourth session
Various
Chairs:
DANKO MILOSEVIC
(Zagreb, Croatia)
VARVARA ASKITI
(Athens, Greece)
16:00–16:20
Oral 12
Acute poststreptococcal glomerulonephritis: From dogma to evidence
VELIBOR TASIĆ
(Skopje, North Macedonia)
16:20–16:40
Oral 13
Atypical poststreptococcal glomerulonephritis
DUSAN PARIPOVIC
(Belgrade, Serbia)
16:40–17:00
Oral 14
Membranous nephropathy in children: Epidemiology, treatment and outcome
JULIEN HOGAN
(Paris, France)
17:00–17:20
Oral 15
Membranous nephropathy: diverse pathogenic pathways, similar morphological lesions
FRANCESCA DIOMEDI-CAMASSEI
(Rome, Italy)
17:20–17:40
Oral 16
Challenges and advances in Crescentic glomerulonephritis
VALBONA NUSHI STAVILECI
(Pristina, Kosovo)
17:40–18:00
Oral 17
Goodpasture syndrome
MARIA GAYDAROVA
(Sofia, Bulgaria)
18:00–18:30
Discussion
Fifth session
C3 GN, IC-MPGN
Chairs:
DIMITAR ROUSSINOV
(Sofia, Bulgaria)
SEVCAN BAKKALOGLU
(Ankara, Turkey)
08:30–08:50
Oral 18
Renal tubular acidosis
FRANCESCO EMMA
(Rome, Italy)
08:50–09:00
Scientific symposium
Fabry disease in pediatric patients
MARIAN STEFANOV
(Sofia, Bulgaria)
09:00–09:20
Oral 19
Pediatric C3 glomerulopathy: from diagnosis to clinical management
VARVARA ASKITI
(Athens, Greece)
09:20–09:40
Oral 20
Complement in C3 glomerulopathy: Analysis of acquired and genetic drivers
NORA VESZELI
(Budapest, Hungary)
09:40–10:00
Oral 21
Does a new targeted complement therapies promise a better future for patients with C3 glomerulopathy?
DANKA POKRAJAC
(Saraevo, BiH)
10:00–10:20
Scientific symposium
Novelties in treatment of children above 12 years old with C3G and primary IC- MPGN
10:20–10:30
Discussion
10:30–11:00
Coffee Break
Sixth session
Secondary glomerulonephritis (Part 1) – LN
Chairs:
REZAN TOPALOGLU
(Ankara, Turkey)
DUSAN PARIPOVIC
(Belgrade, Serbia)
11:00–11:20
Oral 22
Hidden inflammation: Why renal biopsy still matters in pediatric silent Lupus nephritis
ADRIAN LUNGU
(Bucharest, Romania)
11:20–11:40
Oral 23
Complete remission in Lupus nephritís – is it important?
KJELL TULLUS
(London, UK)
11:40–12:00
Oral 24
Pediatric Lupus nephritis: emerging treatment strategies and future directions
PATRICIA COSTA-REIS
(Lisbon, Portugal)
12:00–12:20
Oral 25
Rapidly progressive Lupus nephritis: Therapeutic dilemmas, guideline-based management, and outcome
BRANKICA SPASOJEVIĆ
(Belgrade, Serbia)
12:20–12:40
Oral 26
Corticosteroid minimisation and treat to target in paediatric systemic Lupus erythematosus
STEPHEN MARKS
(London, UK)
12:40–12:50
Discussion
12:250–14:00
Lunch Break
Seventh session
Secondary glomerulonephritis (Part 2) – ANCA GN
Chair:
CONSTANTINOS STEFANIDIS
(Athens, Greece)
BRANKICA SPASOJEVIĆ
(Belgrade, Serbia)
14:00–14:20
Oral 27
Clinical presentation of ANCA associated vasculitis
REZAN TOPALOGLU
(Ankara, Turkey)
14:20–14:40
Oral 28
Management of ANCA associated vasculitides
SEVCAN BAKKALOGLU
(Ankara, Turkey)
14:40–15:10
Oral 29
International Cooperation and European Networks
MAREK MIGDAL
(Warszawa, Poland)
15:10–15:20
Discussion
15:20–15:30
Closing remarks
15:30–16:00
Coffee Break
Round table
16:00–17:00
C3 and IS-MPGN in SE part of Europe – testing, genetics, access to treatment
17:00–17:30
Discussion
| All registered medical professionals have free access to the scientific lectures. |
Registration includes:
- access to all scientific sessions
- access to the partner exhibition
- coffee breaks
- two working lunches
- delegate kit
- electronic certificate of attendance
HOTEL ACCOMMODATION
| Conference hotel | Single room | Double room |
| Hyatt Regency Sofia | 155 EUR | 175 EUR |
The accommodation rates are per room and include: one overnight stay, breakfast, unlimited access to high-speed Wi-Fi and insurance. The listed prices are final, in accordance with Article 86, paragraph 1 of the VAT Act Implementing Regulations.
The price does not include a tourist tax of €1.67 per person per night.
Parking – BGN 20 / EUR 10,23 per day for hotel guests (payable directly at the hotel reception).
Cancellations are possible until October 02, 2026.
Only medical specialists and members of Health and Patient organizations are allowed to participate in medical events, after filling out a registration form. Accompanying individuals are not allowed to attend. Within the framework of the scientific forum, no entertainment services will be provided.
As a professional organizer of medical events and in accordance with the ethical principles of professionalism and responsibility, when planning, organizing and implementing its activities, MEDICON GROUP fully complies with the Code of The Association of Research-based Pharmaceutical Manufacturers in Bulgaria (ARPharM): effective from 1 January 2021.
Additional Details
Платени регистрации -
Безплатни регистрации -
Билети за дарения -